Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Vibrio fischeri ES114, ES114

>VF2172 ABC transporter ATP-binding protein
MYALEIEQLRKTYSGGFEALKGVSLTVEKGDFYALLGPNGAGKSTTIGVI
SSLVNKTSGKVQVFGYDIDTQLVQAKQQIGLVPQEFNFNPFETVLQIVMQ
QAGYYGVSRSLAKERAQKYLTQLDLWEKRNDRARNLSGGMKRRLMIARAL
MHEPKLLILDEPTAGVDIELRRSMWEFLKQINEQGVTIILTTHYLEEAEM
LCRNIGIINKGEVIENTSMKSLLNKLQVETFILDLAENSPVPVLEGAKVT
SCKNGSIEVEIDKSQGLNYLFEQLNHQGINVLSMRNKANRLEELFVSIVR
SGEAK
>VF0327 ABC transporter ATP-binding protein
MNIIELSNLTFHWPNQSELTLNIPSFTQKQGSKLFIKGPSGSGKSTLLSL
LTGILSPTSGCVTINGTDINQLSSNQRDRFRADNIGYIFQQFNLLPYLSV
IDNVILPYQFSSKKTLSIKELRIEATRLLTQLQLPASHFNKPITDLSIGQ
QQRVAAARAFIGKPKLIIADEPTSALDHETRFAFIELLMNECGNSNASLL
FVSHDPSLESLFDQSIDLRELNKAGGIS
>VF1277 transporter
MSSTITSTINWNWLLRQAKNYKTRLVAANVIAIIATLISVPIPLLMPLMV
DEVLLHKPASGVEILNHLLPTAWQNATGYILLVLVLVILMRVISQILNII
QGRQFSLVSKTITYQIRLQLLDKLSRISMKEYESRGSGGINSHIITDIDT
IDKFLGPTLSRFIVSFLTVIGTAGVLLWINWQLGLFILLVNPIVIYFSRK
LGNRVKDLKKKENQSYERFQSRLIETLDGIYQLRASNRERLFLEQLKNQA
DDIRHSADQFAWQSEAAGRLSFLLFLLGFELFRAAAMIMVLFSDLSIGQM
FAIFSYLWVMLSPIQELLNIQFSWYGASAALKRINTLLHIDEEPKIHSDI
DPFYKSSTAEISINNINFSYNEECQVLNDLSLNIRAGEKVALVGASGGGK
STLIQLLLGLYQPSNGTITFNGHSTKEIGFDNIRNQISVVLQQPILFNDT
LRHNLTLGADYSDDLLWEALNVAQLQDVVAQLTEGLDTQIGRQGVKLSGG
QRQRLAIARMVLTDPKFVILDEATSALDTATEAALHKALSDFLVGRTTLI
VAHRLSAVKQADTIYVLDDGKVSQSGTHHELVTQQGLYQTLYGTIQS
>VFA0307 peptide transport system permease protein SapC
MLSNNVYQEEHIPTQMERFWLSYRANSLAMFGFWCLLLIVIITVTSPWLS
PYDPQWQSDYLLMPPSWSSEGEVIFFLGTDDLGRDILSRLLMGSQLTFGY
AVIVALLSGFVGCVIGIFAGMTKGLLSSTLNHLLDTILSIPSLLLAIIFV
AFLGFGEFNILLAIWLALIPRFVRAVYTAVHNEVEKDYILAARLDGANNF
YLLWNSILPNILVVMVAEMTLAISIAILDITALGFLGLGAQAPSPEWGAM
LGDSVELIYTAPWTVTLPGIVITFTVIIINLVGDGIQRALNAGTE
>VFA0308 peptide transport system permease protein SapB
MWIYTIRRFNLFVITLLILTLIGFNILRLDDTSAWAQTPFLSGWLTYLGQ
LLNGNLGVNQYGVKMLNEILRVFPATIELCFFAFFIALIIGTPIGTIAGM
RRGKPLDTLISSIALVGYSMPLFWIALLGLQLGVTPVSGRYSLLYEFDAK
TGFAFIDVLASKSPYRAEMLENIIQHLILPTLVLSIAPMTEVVRLMRSSV
ATVITQNYIKVAHTKGLSKFEIMVKHIIRNALPPIIPKLGVQLSGLFTAA
ILTESIFNWPGIGHWLLDAIINQDFVAIQAGVITVASFILLANILSDLLG
AAVNPLVRKEFYALK
>VFA0589 integral membrane protein
MSLFLLIQKEAKAIFSNTTIVLAMIGGVLFYAFLYPLPYQHQSPEEQKIS
VVDLDKSELSRKFARMVNTSQQVNVVEQANSIEQAKSQFLNNEITGFLVI
PSEFSKKLQLGEAPTVGYAGDASYFLIYGTIVEGLMTAGGTISAEYRIAH
LAIDGTPMNAAIHSFRPFQSNYIPVFNHYMGYVQYVVPAVFVLILQQTLL
MAVGVRQKQSSANENTVTHLIVRFGIFLFTELLLACLYFGYFFDFYSISR
FGTPLEILVLLVPFISSVILLGLFLGKVLPTSESILLLVLFSSMPIVFSA
GFIWPAEMVPSIITDIMHLLPSGFAINGFLKLNQQGAGLGGVLTNLSGLY
ARCILYAFLFFITRNKNNLKGDTE
>VF2524 acriflavin resistance plasma membrane protein
MRFTDVFIKRPVLAVSISFLIALLGIQAIFKMQVREYPEMTNTVVTVTTS
YYGASADLIQGFITQPLEQAVAQADNIDFMTSQSVMGQSTITVTMKLNTD
PNAALSDILAKTNSVRSQLPKEAEDPTVTMSTGSTTAVLYIGFTSDELVS
SQITDYLERVVNPQLFTVNGVSKVDLYGGMKYALRIWLDPARMAAINMTA
TDVMGVLNANNFQSAAGQATGEFVLYNGSANTQVSDVEELENLVVRTNDG
EVVRLSDIAKVSLDKSHDVYRASANGQEAVVAAINAAPSANPINIAADVL
ELLPQLEKNLPSNIKMNVMYDSTIAINESIHEVIKTILEAALIVLVVITL
FLGSFRAVIIPIVTIPLSLIGVAMVMQAMGFSWNLMTLLAMVLAIGLVVD
DAIVVLENVDRHIKLGETPFRAAIIGTREIAVPVIAMTLTLGAVYAPIAM
MGGITGSLFKEFALTLAGSVFVSGIVALTLSPMMCSKMLVANEEPNRFEK
KVHHILDNMSERYERMLNVIMTRRPVIIAFAVIVFASLPLLFKFIPSELA
PSEDKGVIMLMGTAPSNANLDYMQNTMNDVNTILSNQPEVSFAQVFTGVP
NANQAFGIASMVPWSQREASQAEVTKRVGTLVQDVPGMAVTAFQMPELPG
AGSGLPIQFVITTPNSFESLFQIATEVLTGVKGSPLFVYSDLDLNFDSAT
MKINIDKNKAGAYGVTMQDIGITLSTMMADGYVNRIDLNGRSYEVIPQVE
RKYRLNPESMNNYYVRSASGEAVPLGSLISIDVIAEPRSLPHFNQLNSAT
VGAVPTPGVAMGDAINWFEDVANNKLPSGYNHDYMGEARQYVTEGSALYA
TFGLALAIIFLVLAIQFESIRDPLVIMVSVPLAICGALIALAWGAASMNI
YSQVGLITLVGLITKHGILICEVAKEEQLHHQKSKMAAVTEAAKVRLRPI
LMTTAAMIAGLIPLLYATGAGAAQRFSIGIVIVAGLAIGTLFTLFVLPVI
YSYLASEHKPLPVFEEGKEIKES
>VF0326 permease
MIGITKLAWKSLINRKTTVLLTVATIAISVMLLVGVERIRTEAKNSFANT
ISNTDLIVGARSGQVNLLLYSVFRIGNATNNIDWKSYQEIIHQRAVKWAI
PISLGDSHKGFRVMGTNQDYFRFYQYGKKQPLEFKEGKSFNGLFDVVLGA
DVANKLNYHLGDKLVIAHGISDKSFTRHDNLPFTVVGILKPTGTPVDKTL
HVSLEAISAIHVGWESGAHLGNTPDAKVLEKQKFEPAEITAFMLGLKSKI
QTFALQRYINEYSKEPLSAILPGIALHELWGMMSVAEQALLAVSVFVVAA
GLMGMLTSLLTSLQERRREMAILRAMGAQPKHIFILLISEAVVITSFGII
VGLMGLYLSLSILQPIIQQYYGIAIELTLPTLYELKLLGLVLCSGFVIGV
IPAIQAYRHSLSDGMTIRL
>VFA0743 multidrug resistance protein A
MQAAEQKFKQWMRILIVLFLIVTAYLVMADRLTPLTTQSKVQGFVVQISP
EVSGRIVEVNHTNNQLVKKGELLFKIDDEKYLLAVQKAKIALAQAKEQEA
SLVADIEAARSNVKTTQVTANNANREYHRIKRLANSGAVSASGLDSALTK
RDQAAANLMAAKQKVHALEVKLGKGNGQSSAVLSAKNSLKQAELDLEHTQ
VVAQNEGIITNMQLHVGVFANANQPLLTFIPTDSLWVSADYREKATSEMV
KGMRAEVAYDAMPGEVFPLIVESRDYGVASAQQKANGQLSSVEVSNRWVR
DAQRVRVNLTSDEPLSPRLFVGSRATVIIYTSGNSVIDYIGHSLITMISY
LHYIY
>VFA0112 export ABC transporter permease protein
MKSMNRMKAIMMKEIRQLSRDKLTFGMVIMIPLIQLLLFGYAINTDIRDI
PVAVVDQSESTLGRLITESVKVTQVVNIKQYYPTVEEAEKAIQQGVVRAA
LVLPKDITQRVMQKRELGQWIVDGSDTMISAAILSLQTMPLADLDFDVRN
TAKAKTFEVTLFYNPSRRSAVNIVPGLLGVILTMTMVLFTSSAIVRERER
GNLELLITTPIRSFELMVAKIIPYIFVGLIQVLIILGLGYAIFDVPINGS
LSQILFGTLLFISASLTLGLVISTIAKTQLQAMQMTIFILLPSILLSGFM
FPYEGMPVIAQWIAEVLPATHFMRLIRGIVLRGADLMDLWRDTIWMIVFT
LIGLFVASKRFKKSLD
>VF2440 Na(+) driven multidrug efflux pump
MWNSLRNLSLHRQVLALAIPMVLSNITIPLLGLIDVAVIGHLEHAWYLGG
VAVGGTMISVTFWLLGFLRMATTGLTAQAYGAENKNALSQTFSQGIFLAL
CFSFILLLFHQPLSQIIFSFSDASVEVKHYAEQYFSIRIWSAPAALSNLV
IMGWLLGTQNARYPMWLVIITNSINIILDLLFVVGFHWKVEGAALASVIA
DYSSLVIGLWFVLKQSNKLVLPSFIMSLSDLLSGFKRLLNLNRDIFLRSL
CLQACFTFMTFQGASLGVDIVAANAVLMSFLMMISYGMDGFAYAMEAMVG
KAIGAKSRTQLTDSLIGTTFWSLVISSLLSLVFGVFGYQLIAMISSIEDV
QKTALIYLPWLIAMPLVSMWCFLLDGIFVGATKGSEMRNSMFIAMITFFS
VWWLMQDNGNHALWAAMISFMAMRGVSLAVTFYYQWKKAIFLS
>VFA0467 hypothetical permease
MDVKFHLEKKNKPTSDNGMKVLYGMEKRGAYRFRWYLILAIILSPIFFMI
YTFAKQHLFTVAPGIITTGPVIITASQNGTVKLIDVKDSEFVLEDQLLME
LDAPILEQEIEFIENELEQLYQEQTQKITEDFGPYISAIGAAKLNLKKIT
KIKVNYDQYAKEGKVSQVDYAAIVGIYNTAQNNLTNAYIALNQAEIAQKQ
RLLAGGVAQVTRELNQALTTKKNQLDALSIRAPYMGLVIDINALKGQQIS
IGDPLVTVSPDVAPYVISYLDPKHIEKAKLGALVTVKLPNGKKVEARVSS
AIGLTSKLPIQLAKPFEGAKALLKVKITFLGGVLEKEWVEGMPVEVYF
>VF0885 ABC transporter permease protein
MLFPVAKALLGHYRKHPLQIFLVWLGLTLGVALLVGVLAINHHAKVSYSE
GEKLFSNPFPNRIRSIQDNVVIPQAFYINLRRAGYTSCMPIQTLHLETNE
KIDISMVGIDPIALMQISSGNLANTDNMLSLMRPPFPVLISKPLASYFSL
KDGDYIELKNQSNIGPVIVDKQNRLAGSRLFSDIALTKMLGHKAGFNIIL
CGAMSEQKKERLERMLPRGLQLETHKESGLTALTNAFHTNLLAMGMLSFI
VGLFIFYQAMSLSFVQRQPLVGTLRQIGVSTKELILAMSLEVIIWIIIGW
ISGNFFGLLLANELMPTVSNSLYSLYNAEVDLLISWSWDWSYQSLLMAVL
GCVLACGWPLYRLLTIEPIRLTARLSLARFAGKEFEVQAIIACVIFVAAY
LINLLPHSHRNGFMLIGFLMISIGLLTPFIIWKFFDWLSYTLPSAKARWF
FSDSAASLSYRGVAAMAFMLALASNIGVETMVGSFRATTNNWLEQRLAAD
IYIEPSKASAGRISYWLEKQPEVKSVWRQWKIDYQTEFGNLEIISTGSTE
GEKNALTMKVAIPDYWYSLHHGRNVLISESMSLKWDLKPGDYIDLPAPMG
NNWQISGVYYDYGNPYNQLLLSHGTWLKAFGGQGKTGIGVVLTDQAKRTE
LIGRVLKQYRLSAEQVSDNNNIQIQAMRVFDRTFIVTGTLGNLTLVIAVF
GLFFATLVGEISRQRQTALLRCLGLSGKELVLLGGLQLLVIGLFTILIAL
PLGLILSQLLIDIVMKYAFGWTMEIHYFPKEYTITFLWTLLALTVAGAGT
IWRVTKRQAITSLRESL
>VFA0136 hypothetical protein
MSVEYYVDKFRNLNMNSNKGRKSPHKVCMLLSVMDLIQAGYIYKNRFQLD
ATLKERFTHFFNERRHEQDRDTPENPFFHLKSEGFWHLAYQDGIDASLVK
GYSAKAINYAYLDDELFDYLKSIIVVNDLKDALVENLSDLTDLYTQWLID
VGKSEKTAKNYSQAIRGSISNWMIQENILEEPLTKVKSFREFCRLSETAR
SLEKFKKFNANGNHMYSAALNSYQRFLADLSQVDVKADIQEIFEDNKLTQ
TEKTIMVNTRMGQGTFRKQLIEMWKGCSVTGYKNTQMLVASHIKPWREAN
NTERLDKYNGLLLLANLDKAFDLGFISFQNSGKLMISSQLEAPEVLGLRD
DMIFNVHREHKKYLDHHRKILFKGF
>VF2171 ABC transporter permease protein
MMNLYWTAFKSLISKEINRFVRIWVQTLVPPAITMTLYFIIFGNLIGSRI
GEMSGFSYMEYIVPGLIMMSVITNSYSNVASSFFSSKFQKNIEELLVAPV
PNYIIIAGFVGGGVVRGLLVGALVTCVSLFFVDIQIAHLGVIMLTVLMTS
IVFSLGGLINAVFARTFDDISIIPTFVLTPLTYLGGVFYSISLLPEFWQG
VSKLNPIVYMVNAFRYGFLGVSDVGIGTAFAVLSVFIIALYSIAWHLVSK
GIGLRS
>VF1164 export ABC transporter permease protein
MLLPMRLIFQEMAAEKVRLSLLLLAVAWATLCIATMLAVGEGLRQGVIRS
SESGNGKLIYLTGGYATINSSNFYIGKALQLTSEDLKVIKVLPSVKHAQL
SAIWDEQANYKDHRTWQKPLAVYPDYQALTGLKIVPGGRWFNLLDIKEQR
KVIILGESAAISLFNESNDFDWMNPPKLKVDPVGKKIKLGSEEFIVIGLI
KRSSANIEQGIPLNESLFIPFTTWKRFHQNSAISAINIELMANADRKQVA
KTVKQVIARKYGASIEDDKLLQVEDMLLKQKTIRQFLIGLQGFLGIIGLV
TVGVAGIGIANVMYATVKRSTKDIGVRMAIGATPITIRLHYLTQSLFTMS
VGGGMGLGLTYFLMLLIQALPLAGNDLYDELGQPTPELSLPIVGLIILAL
GLVGILAAWFPANRAALITPLEALQSE
>VFA0424 phospholipid-lipopolysaccharide ABC transporter
MTIEKDESTWATFKRLWPHISLYKAGLGVAVVALVINALSDTYMISLLKP
LLDEGFGSADSDFLKKMPFIILAMMFIRGLSGFVSGYCMSWVASNVVMRI
RRQIFNHFMHMPVSYFDQESTGRLLSRITYDSEQVAAATSKALVNIVRES
ASIIGLLGLMFWNSWQLSLVLVVIAPVVAFAISNVSKRFRKISKNMQTAM
GSLTATSEQMLKGHKVVLSYGGQKVESERFDNISNHMRQQNMKMVVAQGL
ANPIIQMIASFALVTVLYLASVDSIKETLTPGTFTVVFSAMFGLLRPLKG
LTSVTSDFQRGMAACQTLFELMDMDKEKDDGTIEKDTVKGDIKVDNVTFT
YPTADGPALRNVSFDLPAGKTIALVGRSGSGKSTIANLFTRFYDVDSGEI
SLDGDKIEDYRLPNLRKHFALVSQNVHLFNDTVANNIAYASEGKFTRLEI
EKAAELAYASDFINKMDDGFDTMIGENGASLSGGQRQRIAIARALLQNAP
VLILDEATSALDTESEKAIQSALDELQKDKTVLVIAHRLSTIEDADQILV
VDEGEVVERGNHAELIAHDGAYAQLHRIQFGD
>VF1332 Na(+) driven multidrug efflux pump
MKKILTLAFPLIVSQLISMALVLTDVWMMSRLSVSALAGGGLGASVYFFI
FIVASSTVGCVANLIAIAYGQRLARPEFGNQQIRLAIKGAVLLSVILSVI
LLFAFSYAPNVLRLAGQPEEMISLAMEYVDALKWAMFPSLILLVLRGLTS
ALGNVRSIMVMSVITVVLNVPISYVLTFQLGMGLYGLGLGTAVAALMVML
GYGLWVFKQQEYKPFAPWLNLEEYSIKLITPLLVMGLPIAVAALLEHGLI
YGGTLMAGTISIASLALHQILLQCLSFTWNFNFGFSQAAAILVGRDFGAN
NVDGIKKTSQHSFVLVTVMSVFIAAVFIIWPESIADLFQLDNGENNMSAL
LTSVIWVVALCFVVDAWQLLAINLLRGMKIVSLPTVMTAIGYWVCGLPAA
WYLMPIFGLSGIWAGIGIGLGVTGILLLVQLLISIARVKTHYQEIEN
>VFA1103 multidrug resistance protein A
MKKSRHFSITFTLFFISSLIGYLIYFAWQYSNNHPSTENAYVRAKIVSIA
PQIKGRIISVEVNDYQKVNKGDLLLKIDPQPYLLAVKRAESAYQLAVQQH
QVADSKVTQAIANLNGVTSNLKETQIEFKRTQALVSRKLSSQQELDIIKN
KLAIAQAKLEEARANVEAAIANRGDDNGVDAAIVQQASAELAQAELDLSY
TDITAPTDGLLGEINVFVGSVVKNSQMLFPLVVKNTYWVRANFKETSLTN
IRMGQTAEVVIDMYPDITWQAKVSELSPASGTSFSLMPPENATGNWVKIK
QRYPVKLILDIPKDSPQLRIGASAEVTINLSDDSRT
>VF1099 beta-lactamase
MKIKPFLFGLIVLANNAIAGSLTQNIEAIELSSGGYIGVSVLNTETNKTW
AYKGDQRFPMMSTFKTLACAKMLYDSSVGGIDKYKTTSITKEQIMPWSPV
TEPLIGNMITTQKACEATMLMSDNTAANIVLNEIGGPSSLTQFLRAMGDT
KTRLDRIEPELNESKNGDKRDTTTPVAMSQTLNALLFGNTLNSQDEQTLK
SWMMNNKVSDPLLRSILPNDWSIADRSGAGGFGSRGITAAIWNDKHQPII
ISIYLTQTKLDMAERNQVIVEVGNAIFKEFKIN
>VFA0656 hypothetical protein
MYPDIILLNGTGSSGKTSLAKELQELLSIQYLNFSIDSVLYALPPTDLRR
MIAGDPISRSGYDYGQLTEGYHNCVKGLLEAGCRLIIDNAWINEDEINAL
EKSLSGFNVVRVKVMCRLDVCIARELARGDRAIGLAESEYPLVHNFIKYD
ASVDTSDIQPKDAAVKLLRELKLY
>VF1380 penicillin-binding protein
MNRYTLSFISLPLLLSSALSAKDLNIGQYFTIQDNETPGCGVGIVQSDKL
IEQLYVGQSNIRYQTPIDNKTVFDIGSVSKHMTAYIIMALESEGLLSQKQ
TLADFYKDGPDWFNNVTLFHLIHHQSGIPDYLNDTESALYLMKRFKTNDK
ELNTALWGGMVDKSYLFSEIVGFSKQLKSPTFTPGTSISYSNTGYVLLAD
IIEKVTNNKFEDEIASRIFIPLKMSNTQASTKDNFLINWKASSYYVDKYG
NYAHSHTMLPSQGDGGIQSTVPDMAKWMEHLIKPKYADEAREKLLALSKG
EYPAFTTYWGAVEFKMGDSKYVNGLIAKNLYGGEFYSHSGYSLDGMVTEF
WFSPEREVGYIQMCNYKYLKMPPLNNIVQQYGKGN
>VFA0912 ABC transporter ATP-binding protein
MELIMVLLLNNHNQFNQLRHRMNPIITVSSVSKHYPDSNQAQQALDNISF
TLSSGQVLGLLGHNGAGKSTLINALLGAHRFSGNITINGLEPIENHAELM
KHLAYISDVNVLPEWMTIKQILKYTSGVHPYFDINKALSLITKTNIKLGS
KIGSLSKGMKVQIHLALVIATNVKVLILDEPTLGLDLLYRDNFYNDLMAW
FNQGERCLIIASHEVNEIEKLLTDVLILKQGKCVKLDNMNNIPKGTLADL
FITLQKEVI
>VF0975 multidrug resistance ABC transporter ATP-binding and permease protein
MSKEQAQQPSDMFLFKRLVAYSLPHKMRFIVAFMMLSVAISAEMAIPWMA
KIILDDVIVPQQFEWPHLIGLVSLVMVFYVISALFTYLQAVSFRHSALLV
INDVRKQLFNHVLNFPISTFDKLSAGKLVSYITNDTESMRDMFVSTIPTI
IQGSLRIIAIFIAIAILDWRLMLLSLVLIPILLTTMHLYRKISMPVFNGI
REQVSNINGRINESLQGMSLIQAFNQEKVFKDKFEKENQRWFEFRTKSIA
IDSLMLIPLTRLVSNLTAVGIVAWFANASLTTVVEIGTLYAFLNYIERFF
DPFRQLSMELRKLQVATVASKRVFELLDEKSEQNRYPQEFAELVTPHDIE
FKNVNLSYDEEHLVLSDVSFVAKGGKFTAIVGHTGSGKSSVINLLMRFYQ
HQKGSILIGGQPIESLPEIQLRKMFGLVSQDPTIFSGSIIENIDLSHSTP
DKEKVIAAAQQVKAHQFINRLTNGYEHQPGHGGASLSVGERQLLALARAI
SHQPSIFLLDEATANIDSETEEAVKEALENIQDGRTVIMVAHRLSTIKNA
DQILVMNKGKVVQSGTHDELIIQDGDYRSLYLAQKAQEENEHQNSTLGLA
GINAA
>VF0298 acriflavin resistance plasma membrane protein
MIKFFARHPTAANLLMLTLLLLGLVSLSQLKRETFPEFSPPYILAGVVYP
GASPQEVEESICIRMEDAVDGLGNIEETKCEAIEGSARLVIKLNEKADIG
RMLVDVQTQIDSINDFPTEIESPIVQELDWNEPVVDVAITADTTWPELKA
YAEKLKQSLKLDYDVSLVEVSGFSDHQYRVELDETAIRQLGLNVSDIANQ
LAQQNIKLPSGNIETPEKNFLIRFDERKTTPEELAKTVIGASENGALLRL
GDIATITDRFELDEQKVLFDGKPSAVLKISKNKADDALRIKDRVSEFVEY
QQSIAPDGVTLEMTNDLSSLLWDRLTMMVKNGWQGIILVFLTMWLFFTFR
YSFWVAAGLPVAFLGGLFLMASLGLSINIMSLVALLMAIGIMMDDAIVIA
ESIASHLDRGQKIDDAVYNGVKKVFPGVLSSFLTTVCIFGSLMFLQGEMG
AVLKVIPQVLILVLSLSLIEAFLILPNHLSHSLHRAKNDKPITGFKKKVL
DRFEHFRNTTLVNAVTKVVEWRYAFLGAVIASLLVSFSLISGGALKFVGF
PELDGDIAEARIILPPGSSLSQTELVVDKIVNAANKLNKQWSEEKEGGTP
LVEHITEQFNTNADANESGPHLATIRLDLLSAEKRNTLIDDFIDAWREEV
GDLAEPIAMVFKQPTMGPGGRAIEIRMMDDDLHTLKSASLEVQAYLNDFA
GVYGVLDDMRMGKEEVLVKLRPGAEAYGVTGQLIANQLRAAYFGQTADEI
QLGVENIEIEVRLNKQQAGDLHTLENFPIILPTGDQIPLASIATLDFQRN
YVRIQRINGLRTLSVFGDVHASQVSSTEILNQFKKDLAPELKKKYPGLRF
DFEGEAKDSAETGQSIGTGFMLGLFGVFVILSFQFRSYLEPFVVMLAIPL
ALIGVLWGHVLLGHPLSMPSIMGFVSLAGIVVNDSILLVQYIRHHVDDGD
SVYESVIKASRERFRAVFLTSITTAAGLLPLLLETSLQAQVIQPLVVSIV
FGIFTSTLLVLFMIPAAYAILADFGLVKKHEELH
>VFA0479 hypothetical protein
MKVKFHLEKDKQPTSDNGMKIIYGSAKRGGYRFRWYCILALVLSPILIMA
YVFFQQYILTLAPGIITTSPVVITAPQDSMVTAINVKEGNQITYGRNVLE
LNDPVLDSDIQFIKTELTNLNKRKSKVQHDLKSYLLAIRNAKDNLESIKK
IKLNYDKFIKEGKVSQVDYANIIGMYNSAQNTLTSADIGYQKALLDSVQV
ELAGGIAQVVRSLNQELVTKLSQKKLLSIHSPYDGNIIEINTVVGQRIKK
GDVLATIASKADPFVIAYLEPKFIEKAKEGSVVTVILPNRERLKGNVSLA
IETTTKLPAQLAKPFEGPKSLLKVKVTLKKKITKEQWVEGMPVQVSF
>VFA0046 transporter
MNIAEYSIKNKVISWLFITILTIGGITSFLDLGRLEDPAFTIKDAMVVAT
YPGATSKEVEEELTYPLEKAIRKLPYIDKITSTSSNGMSQIMVSMKMDYG
PDELPQIWDEMRRKINDLKPTLPQGIQSLQIIDDFGDVFGVMMMLTGDDY
NYVELKRYADTLTRELELIDGVGKISIAGDQQEMLFVEISLDRLAALNLD
MNTVAGLLNQQNNVVQAGEVLVTWQQQLQRIRTKWQHYTTVESLGALDHP
WP
>VFA0379 fusaric acid resistance protein fusE
MDLLLILTYTALCIAVFKIFNIPLNKWTVPTAGLGGVVLVGTLVLLMNYN
HPFTQFGGQFYVTTPIVPSVRGKVIEVNVTPNQPVAAGDVLFKIDPIPFQ
AEVIRKQAALSEAEQAALQLESVYKSAQSNTIKATADKDKAYREFKRYEK
GYKKGAFTAQQLDTRKQTYKASEATLESVQAQEQQAKLALESEINGENTT
VARMRAELEQAQFNLDETIVKAPTDGYVTQMALRPGMMAVPIPLRPVMTF
VHTEDQYFVGAFRQNSLQRLRAGFEAEFLFRAIPGRVFKGEVVEVIPAIG
EGQIQASGALLGTNAIRTNGRALVKLKLTDDVSEFHLPAGSNAEISVYSD
SFEHVSIMRKVLIRMKSWQNYLYLDH
>VF2245 bacitracin resistance protein (putative undecaprenol kinase)
MTYFEAFFLALLQGFTEFLPISSSAHLILPSAILGWSDQGLAFDVAVHVG
TLAAVVIYFRKEVVTLLTAWVGSIVKKEHNKESNLAWLIVLATIPAALFG
LLFKDFIEIYLRSAWVIAATTIVFGLLLWWVDKNATLAKDEYQMTWKKAL
FLGIAQAMAMIPGTSRSGITITAALYLGFTREAAARFSFLMSIPIITLAG
SYLGLKLAMSDISIHLGLLSTGVIVSFISAYICIHFFLKLISSMGMMPFV
IYRILLGSSLLVWLALH
>VFA0539 type I restriction-modification system restriction subunit
MGFTELNSVEHYIIHQISGVNLNDAQCKNQVSEPQATYALQWQFKSSEQL
GRDVNEVLVESELVKALIRLNPEIEANPHLADEVIHKLRAILISVNQVGL
VKANEEFFAWMTGEKTMPFGENNRHVPVKLIDLEDLTRNGYVVTNQFRIH
HRETKIPDVVLMINGIPVVVGEAKTPIRPSVSWLDGAHEVHNIYENAVPQ
LFVPNILSFATEGKELFYGAIRCPLEFWAPWRTEEDDNSKGIGQVSKALG
LTEIGKELIDLLSPVRLLDIMRNFSLFTTNKKKQRIKVIPRFQQYEGANK
IVERVIEGKIKKGLIWHFQGSGKSLLMVFAAQKLRRTAQLKSPTVIVLVD
RTDLDTQISGTFNAADVANVESTDSIKELQRMLERDTRKIIISMIHKFRD
AKPNMNTRENIIVLVDEAHRTQEGDLGRQMRAALPNAFLFGLTGTPVNKA
DKNTFWAFGAEEDKGGYMSRYTFHDSIRDEATLPLHFEPRLVDVHVDKEA
LDKAFKDFKESAALSDEEADALNQKSAKMSAFLKSPERVEKIVEDIAIHF
MDKVEPHGFKAMVVTPDREACVQYKEELDKHFPESASKVVISTSANDDFE
FKQKWGVDKSQQEKLVDEFNDEKSDLKFLVVTAKLLTGFDAPICQTMYLD
KSIKDHTLLQAICRTNRLYPNKTFGCIVDYFGVFDDAAKALEFDEESVQQ
VISNLSELRSKLPQAMQDTLAHFIGVDRSLEGFEGLEAAQNAIGDNDKKD
AFALDFKYLAKLWESLSPDSVLDEYNEDYKWLAQVYESVKPASDNIGKLL
WLALGAQTTQLIHDNVHVGDVHNLEEFVLDADVIENIFNNPDPRKIKQLE
KELAKRFKDRGDLPVFKSLSERLEELRDKAEKGLIASIDFVKELCKIAKE
TVQAEKDLDDELQEKTPQAALTDLFLELKDDQTPAVVERIVTDIDAIVRI
VRFPGWQTTTGGEREVQKSLRKALLKYKLHTDQTLFDRAYGYIKEYY
>VFA0737 ABC transporter ATP-binding protein
MISFKGIEKTYQLGLQRVEALKQVDGFIIKGSMVALCGPSGSGKSTLLNI
LGLLDMDYQGEIKMDGEFYPKDPIEAAKLRRHQLGFVFQRFNLVPVMTAL
ENVAYPLVLNGYSSKEQRILATEMLEKVGLGDVIHHRPDNLSGGQQQRVA
IARALVHKPSLVIADEPTASLDSQTAETVIDIMKALGKEIGTTFIVATHD
YRMAQHCDTCINLLDGTISKEAVSCAS
>VFA0896 multidrug resistance protein A
MLEGLAVWALFIYLLRMVGMPWNKFTQAFAYIGGGSWLLFVWAGLLNYTP
MDLSGGSVVQSPHIQLRPASTQIKGTVKAIHIEPNQEVKKGQLVYELDDE
LYQIALNKAEVAFEASEVALAVAKQNVKLANQAIIASESDVVVSQKQIEA
KSQDLKYKKLTLQRYVEQNRKVKNTITQSALDEQGTLVSIGEIEVASAIA
QLDKAKLANEKAQLDFDNAKLGVKAKESELASAQESVTQAQWNLDNTKVY
APADGYVTNFILREGQYVGTVPRMQMYTNEKYVLMRVNHQAIRNVKVGRP
AEFSSAVYPGKIFVAEVEGIIEATGEAQANLLGRETNVRQTTGLNVNNKH
HFVRLKLQEDQGYDIPVGSVGLAWVSGEKPIGFMAFLDVIRGIIIRMKSQ
IYFFYSL
>VFA0590 daunorubicin resistance transmembrane protein
MISMKTYWRSYFTSPWVMAVTFVLPLLTSLVIWWIFSSNVVRELPIDVVD
LDQSHLSRMMIRDYDATPTLSVKSIQPNKEKANLALTKGDNYGYIIIPHD
FEKNVMLGKSPKITGFYNGQFILIAKQINSALMQTDMTAQAKLSVIKQLS
IKETTWTQAINSAVPIKVQVTPLFNLGSNYNQFLVSAILPAIWQMAVIVG
MLWAMQNESVRTGCNSLREWFDKQDRLSIFNFTLVYFCIAMMLGAVLFYF
LYGVIGFPFNGSITAFILNMSLMSFACISLGIAIGYGTNDIVKAMSISGA
YTAPSFAFLGVTFPVTDMNSLATFWHSILPASHFVRAQNELSNYGDSLVS
AFPNIGVLTLFTLPLLLLSLKLKK
>VF1101 hypothetical protein
MSSDFYGTSAAYARQESGYREKALKLYPWVCGNCAREFVYSNLRELTVHH
KDHDHTNNPSDGSNWELLCLFCHDHEHSKYTEHDQYGTEIRAGEDDHKAA
THNPFADLKAMMKK
>VFA0306 peptide transport system ATP-binding protein SapD
MPLLDIRHLTIELETPQGMVKAVDRMSLTLNEGEIRGLVGESGSGKSLVA
KAILGITKDNWKISADRMRLGNIDLLALSPKERRRVIGREMAMIFQEPST
CLDPSEQVGNQLKEAIPSKYFTGSWWQRWNWRTKGAIALLHKVGIKDHKH
IMKCYPYELTDGECQKVMIAMAIANKPRILIADEPTDELDAVTQSQIFRL
LSRMNQVNNTTILLISHDLITLTQWVDRITVMYCGQSVESACRKDILEAP
KHPYTNALLRAMPDFSKDGIPHKAKLESLPGTIPPLQHLPIGCRLGPRCP
YAQRKCVQVPERQKVKDHKFSCHFPLNFEEKKNDCAS
>VF0203 Na(+) driven multidrug efflux pump
MSTPETYKRSALNPETSLLLFLVPNPSNLTPISYTLTIPPPHEKTMLDKH
GLLTQPISDVLRKLTTPMVFGMVAILLFNLVDTFFISLLGTDALAAVSFT
FPVTFAVNCITMGIGVGLSASIGHLLGEGHSKHAAELTTHGIILAISLIL
IACALGFFTIDPLFTLLGAEDKLLPLIDEYMSIWYLTIPLLVIPMSSNSA
IRATGDTKTPAKIMMLAGLINGILDPLLIFGYGPFPELGIQGAAIASAIS
WLGALIASFYVLTHKVKLLALPNKNTLISDWKQILTIGSPAALSNALNPI
SGAILMMMLASQGTVAVASYGAAQRVESLMLLVIMALTSSLSPLVAQNLG
AKQPERVKEAIFLAIKFSVAFQLFLYILIVPLSIPISHLFSQDDAVQHGL
WMYLICVPFSYGFQGIVMVLVSSLNAMKKPLYSFSWSFMRLFVFTLPTAW
IGSQIYGMEGLFIGIAMGNVMGGISAFWYARTRIRFEDAALEERGDTKS
>VFA0463 Lipoprotein releasing system ATP-binding protein LolD
MSNPLLVCQGIRKVYQEGAMETEVLKGVDFQINGSELVAIVGSSGSGKST
LLHILGALDEPTAGTVHFQENELTKLSANKQAKIRNQHIGFVYQFHHLLA
DFSALENVAMPLLIGGVNKKEAAKRATELLEKVGLAHRIEHRPSELSGGE
RQRVAIARALVNKPALVLADEPTGNLDHKTALDIYNLMRELNQESGTAFL
VVTHDNELAAKLDKQLSMQDGRFITETVRSSLAQEMEA
>VFA0305 peptide transport system ATP-binding protein SapF
MTALLEVTDLKKDYVFRTGLFRKQVREAVKPVSFSLEAGQTLGFIGANGS
GKSTLARMLAGVVEPTSGIIKVNGEVLDYKDFQTRCKLIRMIFQDPNSSL
NPRIQIGRILEGPLKRNTSMPPEARQQRVKDTLLRVGLLPEHAYFYPQML
ATGQKQRVCLARALILQPSIIVADEALNGLDMAMRSQIINLFLELQQEMA
ISFIYVSQHIGVVKHITDKVMVMHEGEVVEKGPTEEIFSNPQHSITQRLL
ESHFDAPTHDRKQRISAATPKIEC
>VFA0047 acriflavin resistance plasma membrane protein
MIIHGRDTGNLIRLKDVATITRGLQEKPGNIIRFNGKNALNIGLSFASGV
NVVEVGQRVQEELTYLESIKPAGLELSYFYNQAQEVDTSVRDFIISLAEA
VAIVIVVLLFAMGMRSGLIIGVVLLLTVFGTFILMSYNNIDLHRISLGAL
IIALGMLVDNAIVVVEGILVGLKKGRTKVQAAADIVKQTQWPLLGATVIA
IAAFAPIGLSEDATGEFMGDLYWVLCYSLFLSWVTAITITPFLADLLLKE
EDKNTGVEEDAYKGFLFTAFGSSLKLALRFRWLTVASLVGLLVVAVMAFG
NVKQQFFPASNTPMFYVDMWMPEGTDIRETIKQSEAVESYINKQDNIEFV
SASIGQGMQRFALTYQPEKSYEAYAQFQIRTTDRESMFSLLENLTNSLDQ
RFDKPTFQFKMMEFGPSPASKIEVRISGPDPQILRNLATNVEDIILTDPG
SRNIRHDWRERTKELTPIFNESKARRLGISKEDLSNTLQMAFGGSTLGML
RDGTHTLPIVTRLPESERVDFESLQNVKIWSPSLQTYIPVDQVIDGVNLD
WSEPLIQRRDRKRTITVMADHDLLSDDTPASLLARIQPKVMELPLPEGYE
ITWGGEYESSKDAQESLFGSLPMGYLFMFIITMLLFNSVKKPLKVIWFTV
PLSIIGVAFGLLGTNMPFSFTAFLGLLSLSGMILKNGIVLLDQINLELAS
GKDPYLAIVDSAISRVRPVSMAALTTILGLIPLLFDAFFSSMAITIMAGL
GFATVLTLIVVPVMFAILFKIKPAAQTI
>VF1581 acriflavin resistance plasma membrane protein
MWLSDVSVKRPVVAIVLSLLLCVFGAVSFSKLAVREMPDIESPVVSISTR
YEGASATIIESQITTVLEDQLSGISGIDEIESTTRNSMSRIMITFDLGYD
LNTGVSDIRDAVARAQRSLPDEADDPIVFKNNGSGEASLYINLSSSVMDR
TELTDYIERVLVDRFSLITGVSSVDVSGGLYKVMYVKLQPDLMAGRGVTA
SDITAALRSENIESPGGEVRNDAIVMSVRTERLYNKAEDFNYLVVKTASD
GTPIYLKDVADVFIGAENENSTFKSDGVVNVSMGIVPQSDANPLDVANLV
HEEVAKIQQFLPKGTRLAIDYDSTVFIERSIAEVYSTLFITGGLVILVLY
IFIGQARATLIPAVTVPVSLISSFIAAYYFGFSINLITLMALILSIGLVV
DDAIVVVENIFHHLEKGESPLLAAYKGAREVGFAVIATTLVLVMVFLPIS
FMDGMVGLLFTEFSVLLAMSVLFSSLIALTLTPVLGSKILKANVKPNRFN
LFIDKVFSALERSYRKAVSKAVAWRLLAPVIILACIGGSYGLMQYVPSQL
TPQEDRGVLFAFVRGADATSYNRMSSNMDIVEERLMPLLGKGFLKSFSIQ
SPAFGGNAGDQTGFVIMILEDWEDRDLTAQQGLGVIRNALADIPDVRVFP
MMPGFRGGSSEPVQFVLGGSDYSELQKWGEILKAEANNSPLMEGADINYS
EKTPELVVSVDRHRAAELGIKISDISDTLEIMLGGKSETTFVERGEEYDV
YLRGDENSFNNAADLSQIYMRTSSGDLVTLDTVTKINEVASAIRLSHINK
QKSITLSANLKDGATLGDALNYLDAKAIEILPSDISVGYTGESKDFKENQ
SSILVVFGLALLVAYLVLAAQFESFINPLVVMFTVPMGVFGGFLGLLLMN
QGLNIYSQIGMIMLIGMVTKNGILIVEFANQLRDKGVELEQAIVDASARR
LRPILMTAFTTLAGAIPLIVSTGAGYESRVAVGTVIFFGMAFATLVTLFV
IPAMYRLISGGTHSPGYVEDLLNKELDHDIKGRISH
>VFA0357 acriflavin resistance plasma membrane protein
MDIARYTIAKRTSVWVLIALILFGGYLSYLKLGRFEDPEFVIRQAVINTP
YSGATAQEVSDEVTDIIEGAVQSLQEVKEIKSVSKQGMSEVTVEIKLEFA
GSQAELQQVWDKLRRKVGDAQRMLPPGAGASIVNDDFSDVYALFFAVTGD
GFSDKQLQDYVDDLRRELVLVPGVAKTATLGERQETIFIEMSGERMAKFG
VSAEKVYQVLQKQNMVTIAGSIETDSMRIPVIPSSNVNSFNDLINLQINL
GDNNAVLRLGDIATVTRGYQEPQSMMVRYNGQRAVGFGISNVAGGNVVDM
GDAVKARIAELENQRPLGIELNVISMQSDSVRASVTNFIDNLIAAVVIVF
IVLLLFMGVRSGIIIGFVLLLTVAGTLCIMLIEDIAMQRISLGALIIALG
MLVDNAIVVTDGILVRLQTTPNDSRDDIVSDVVNTTKWPLLGGTVVGICA
FSAIGLSPSDMGEYAGSLFWVILYSMLLSWVFAVTITPMLCYDFLKVKPV
DTQAPVGRVSRWYRQLLTWVIKHRVISLSLLLMVLFTSIYGAKYIPPGFM
PESQRAQFVVDVYLPQGSDIKRTEQTIASIEQDIKQKAGITNITSFVGGG
GLRFMLTYSPEARNPSYGQLLIDIDDYQNIAPLLGELQSELDEKYTDASI
KVWKFMLGRGGGKKIEAGFKGPDSAVLRQLAEQAKTIMLNDPQLIAVQDD
WRQQVPVLRPRYSEEKAQQFGLTTQEINQAIAQTLSGRNVGVYREGNDLI
PIVARSPETERSHQRAIENTEVYSHAVGGFISVSQLVESTDVVWEDAILR
RIDRMPTILVQADPAPGVLTADAFNQVRQKIEAIELPSGYELIWYGEYKA
SKDANEGLVISAPYGFAAMILSVIFMFNALRQPLVIWLTAPLAIIGVTVG
LIIFQTPFEFMAILGFLSLIGMMVKNAIVLVDQADAEIREGKLPYNAIID
ASLSRARPVLLGALTTILGVAPLLIDPFFKSMAVTIMFGLLFATILTLIV
IPLFYAMFFRIKAIEE
>VF0884 ABC transporter ATP-binding protein
MLKLTNLNKGYLDGGEFHPILQGAELTIEQGAQIALMGESGSGKSTLLNL
IAGLDSVDSGEINIAGFSMHAPEQSSRTSYRRNNIGLVFQQFNLLPTLSV
ADNIRFCRQLKGLRDDDALWRQIISALDLMPLLGRYPEEISGGQQQRAAI
ARALYMEPKLLLADEPTGSLDEKNAEAVMRLLTRLSRDLHCTLLLVTHSE
KVAEHMDGLVKLQGGLLNVISGS
>VFA0916 Na(+) driven multidrug efflux pump
MTTFHADSSITRTFWRYAIPSIAAMVVSGLYQIIDGIFVGHYIGFEGLAG
INMAWPAICILGAIGVMVGMGTGSVMSIYRGENKLEKTKVALTTGFWLLA
ILSIIAISCIVLLAKDILLAQGAEGQNFAYAMDYINVLMFGGFFTACATA
LPMLVRNDESPNVATFLLVIGALINIVLDYVFIGVMGLGLSGAALATLMA
QACVTVLGIGYFFTQRSSIQITLQEVLFSWNKAKQSLSLGASALVMYLYG
SFVVAMHNALMMYYGSATTVGAYAIVGYLFMLYYLLAQGIAEGAQPPISY
YFGARENKKVYQIFKIALKWVIITGIGWVTILNISPELTTALFTNGDKAL
IAETIVGIRYHLFAMFLDGMIVLITIYFLSVNEGKKAMVISISNIVIQLP
FLLILPKWFGIDGVWLAMPVSNIALIICIAPMVWNHLKTQKIIKPLPLTS
TSVMSH
>VFA0535 type I restriction-modification system methylation subunit
MIEKLTLSQLEQYLSKAAWILKGPVDASDFKVYIFPLLFFKRISDVYDEE
YRVALEESDGDEEYASMPEMHRFEIPTGCHWRDVRETTTSVGITIEDALR
GIEQANQEYLYGIFGDAQWSNKNKLSDELLINLVEHFSQYTLGNQNVEPD
MLGNAYEYLIKHFADLTNKKAGEFYTPRSVVHLLGMILDPHEGETIYDPA
CGTGGMLLECVDHLKDNKEDYRTLKLFGQEKNLTSSSIARMNMFLHGIED
FEILRGDTLRHPAFFEADGLKTFDCVIANPPFSLKDWGSENWANDPYGRN
IAGVPPKGNGDMAWVQHMVKSLNSTGRMTVVLPHGALFRKAAEGKIRKQL
LDQDMLEAVIGLGPNVFYGTQLAACVMVFKQNKPADKKGKVMFIDASDQI
RVGRAQNFLEPNHVQQIYDWYHNYQDVENYVKVASMDELAENDYNLNIPL
YVEKIIEDNLPSVEEAMADLKQAWQASLEAEEKFKSVLKGFLK
>VF2183 anhydro-N-acetylmuramyl-tripeptide amidase
MKFTLSADHWLNEAKHVASPFYDERSDEDDISLLVVHNISLPPGQFGGPY
IEQLFTGKLDPNEHPFFKVIHQFKVSAHCLIRRDGSVIQFVPFNARAWHA
GVSSFAGRERCNDYSIGIELEGTDFTAYTQKQYEALAVVTNVLQAAYPQI
VNERITGHQYIAPLRKTDPGLSFDWKKYHKLRK
>VF1452 Na(+) driven multidrug efflux pump
MSNQTAKFVHGSTMRHILVMSGASSIGLMALFVVDLLDMFFISLLGQVEL
AAAIGFAGTIIFFSTSVSIGSSIAMGALVSKALGAKENEKAQQLASSTLA
IAFIVNTVVTIVMFCFIPELLSMIGAKGFVAERAQAYLSILLPSTPIIAI
AMAAGAGLRAVGDAKRSMLATLYGGIVNAILDPIFIFGFGLNVEGAAIAS
VISRITVLVFSLYPLVKTHNLVKWPEWSIIKDHTPAIITIAAPAIITNTA
TPIGNAIVTSTLAPFGEDFVAGFAVIGRLIPVTFAVIFALSGAVGPIIGQ
NFGARRIDRVKDTLRNSLFFTAIYCIAVSLILFLLQDYIVKAFNLVGDAS
LIMMTFCSFVAITFIFNGAMFVANTSFNNLGKPLYSTALNLSKATIGTLP
FVYFGAQWYGGLGVLYGQAVGNVVFGIISLIVLRMHVISMVREHCETVCT
EDALADISVTMTPFCNNDAVIMQSGAETDEELEVSVASK
>VF0968 beta-lactamase family protein
MNTVKFKQNVKFFTLLLSLCLLLSGCRNNLVPFTKGQSVDQYVDSLSFSG
AVLIVDQGEIVLSKGVGLVDRKGTETINADTVFRLGSVSKQFTATAILLL
QQKGLLNIDEPVATYLPDFPHGDIISIKNLLQHTSGIPNYTEFKNFGVIA
TQYHSPAQLVAMFKDLPLEFTPGTRFNYSNSGYVLLGYLIEVVSGISYEE
FITTEIFSPLLMTRSGYGENTFGNDNIAHGYTSFGAPASSIDMSVPYAAG
ALSSTLNDLFRWDHSFYENALLTKASKALLYRPGLNNYAMGWAVSTGDNG
RVYHHGGLIHGFSSFIARYPEEQRLIVVLANEEGYDVAGLADQLNKLINS
N
>VF1107 ABC transporter ATP-binding protein
MTIQIKQLCKTYNQDTEFPVHAVDHLDLTIEQGEFVAVIGPSGSGKTTLL
NMLGGIDAVTSGKVSIDNHELTEMDEKQLIEFRRDNIGFIFQDYSLLPVL
TALENVEFVMLLQGHEEAECKLRAQQLLKRVGLEDQQHKRPAQLSGGQQQ
RVAVARALAPRPRFIMADEPTANLDAKSTAELLDIMEALNQEENTTFIFS
THDSRVFERAKRIIVFEDGQLKEDKQQ
>VF0878 multidrug resistance protein A
MTELKKKKNKAPLIATVIFILCGALGAGYWYGYGQYFQSTDNAYLQGDIT
TISSKVGGYIQQTLVEDNQKVKAGDLLATIDDRDFLAEQEKAEANVAVNA
AAITNLNAELKLQDIRIRQSASQIESAQADLERAQQQVKRTKALIKKNYS
SQDELDNNVSHLKVAIANLDAAKANYQASKEQINVIESQIGQANAMLNQA
KTALDQANLNLSYTKIYAPIDGIVGKRSLREGLLVQAGMPLLSLVPTKEV
WIEANFKETQLEKIHHGQKVFVDLDAYPDLHLKGIVESFSPATGAKFALL
PPENATGNFTKIVQRVPVKISILNTDLLDGKLIPGLSVVATVDTRG
>VFA1165 type I protein secretion ATP-binding protein
MKKWKAFNMKDSLLHSLCYVSRYYGQINSPEALINGLPLQDGKLTPFLFS
RAAERAGLVAKENQGELLSIPQLILPVVLLLKGGESCVLIGFDAERKEAE
IITLSSDMLPISISVEDLEAQYIGRYILLKKQFRYDDRSPEILKKREGHW
FWSTLFESKHIYRDVFIASILINIFAIATPMFTRLVYDKVVPNLAFESLW
VLASGIFVVFVFDFILKYLRGYFIDVAGKKSDVLISSKLFQKVLGIRMEA
KPASVGAFARHLQEFESIRDFFTSATIASLIDLPFALLFLFIIYLIAGPI
VLVPVVGITLLLIHAAIIQGPLKKTIEEGSRLSSQKYANLIESLVGLETL
KIFNAQSQYQYRWEEAVTHISNWSIKSRRITDSIQNMAGFVQQAVNIGMI
IVGVYLISNGDLTMGGLIASTMLSGKAIGPLVQISLLSSRYNQAKSSMTI
IEELMAMPDEQEEEKRYIHRPILQGKIELDKVSFNYPEAEVAAVRDISLT
INPGEKVAIIGRIGSGKTTLERLIMGLYKPTAGSVRIDDTDISQLHHVDV
RRNIGCVPQDITLFYGSIRENIVLGRELSDDAEVMDAANRAGVTAFTQQD
PAGLERQVGEGGLLLSGGQRQSVAIARALIGRPPVLLLDEPTSCMDNRTE
MLFKNQLSHLKPAETLVLITHKTSMLDVVDRLIVMEKGHIITDGPKEQVL
NELKTGKVRAVS
>VF1163 export ABC transporter permease protein
MMALFSQTIQTLLAHRLRGFLAILAIVWGIISVLVLVALGEGFYQINMKS
FSLLMNDTQVVFLGQSTTKEWKGRAAKRLIVPSEAEVRQIRNHPAIENIS
VIYSKRNASVTDSQGRSLPRNVTGIDDQFIELRNVKLSKGSRQVNHGDLV
NHKRVALVSWQLADIGSLHIGSSLNINGIPFKVIGITKKNEDGISLGDVS
QAMIPSTVFTDLWESEPDMLFISPVEGVSSWLLRKNILSFFANQQYFDPN
DKDAMYMPDFGQEAAFFKKLLRGIQLFLGANGAMTLVVGSLGVANIMFLS
VTERTREVGVRLAIGATPNNILGQFLIEGGILIACGTAIGIVFSYGIVML
LNMIGMPEWLGEPMITLDAIKISLGVTAVLALLAAYFPARRASNLLPVIA
LSARA
>VF0974 multidrug resistance ABC transporter ATP-binding and permease protein
MNILWKLRGYIKMFSRQYIIAIIALQVVALLSLVPSWLIGRIVDSVSSNE
LTVPYLLVHIGGIVISAIAMYGLRYVWQSQLYGASIAIAKVLRRDLFRKF
SMLSPSFYSRRSTGDLMAHATNDLNAVEEATGMGIMTLVDSFIAGLTVIF
GMIFIVSGELTAVALLPFPFLVYITKHYGINLHKTFGRAQASFAHLNEEA
RETVSGIRAVRSHGIGQRQELRFGKTLDETLEANLAVAKVDAAFAPTIQL
IYGLSFVISLAYGAWLINHDQISVGLFTTFTLYLGQLLGPFLQFGWQFNV
FQRGSTSWKRLDALFSEKEEVVEGSVTLPSDAKASLDINITSFSYQNTNR
RALERINMTVDEGGFIGITGPTGSGKSTLLHLILRQFELEHSSNISIDSY
PVQSLTFHSLRSKIAWVPQKPFLFSGSIAENIALAKPEATEAQIQYVAEM
AGIKNEIDTMPDGFNTELREGGGNLSGGQRQRLTLARALLSDADILLLDD
PFSALDIKTEVIIRRNLKENYNHKTILLVTQRLPNLIEADRIFVLNEGQI
EEQGSHHDLLANQGWYSMVYQRQSQLNTVIGEISIPNGTEMKKLGDHNE
>VF2132 acriflavin resistance plasma membrane protein
MLAIINAALSRSRTMLMLLALLLIAGISTYLVIPKESNPDITIPIIYVSM
SHQGISPEDSERLLVRPMEQELRSIEGIKEMTAVAGEGHGSVTLEFSVGV
DLDKALTDVREAVDLVKPNLPEESDEPTVHEVTLAAEQAVLSVVLYGTVP
ERTAVQIARKLQDKLESYKQILEVDIAGDREDVVEIIVDPLLLESYGLDQ
AAIYNLIALNNRVVAAGFVDTGYGRFSVKVPSVFESLKDVLELPIKVDGK
QVVTFGDIATVRKAFRDPNSYARLNGEKAIVLDIKKRSGENIIETVEIVK
AVLSGAQELDDWPNNLLVKYTWDESKDVKNMLNDLQNNILSAILLVVIVI
IAILGARTALLVGISIPGSFLTGLLLLAVSGLTINIVVLFSLIMAVGMLV
DGAIVVTEYADRRMQEGAHRVEAYREAAQRMAWPIIASTATTLAAFAPLL
FWPDITGEFMKYLPLTLIATLSASLVMALLFVPVLGSLFGKPQQVLPKKR
VKLQALSRGDYSQAEGVTKLYYQTLSFSLKHPFKVLLLAITLAVGIGFSY
AKAGLGVVFFPDVDPPFLTVKVRSHGDLSIDEKDKIMVQVQNQILGMEEL
DSIYTRTGGDDEIGRIQITPIDWQNRRPVKEIIEDLRVKTKDIAGVELEF
STPNAGPPSEHDLVIELSARNGELLNQSITQVRKWVDSNAAFTNVSDTSN
KQGIDWKIDIRRDDAARFGADATLVGNTVQFVTNGLKIGDYLPDDNDEQV
DILVRFPEEHRDIGRFDELRVKTSNGLVPITNFARIIPTHKQDTIHRIDG
HRILSVKADMSEGYNLSIELPKIEMALKNLGLPKGVEFKLRGQNEEQNNS
AAFLQNAFLVALAVMAIILVTQFNSFYQAFLILSAVLFSTVGVFAGLLIF
QRPFGIIMSGIGVISLAGIVVNNNIVLIDTYNTLRKEGIEKVDAILRTGV
QRLRPVMLTTVTTILGLMPMVLEMNIDLVNQKVEFGAPSTQWWSQLATAV
AGGLAFATVLTLVLTPCLLMLGRDKKVRELLD
>VF1266 Na(+) driven multidrug efflux pump
MLDKSNPIERRMQITTLAWPILVEILLRTAISTSDVFMLSGYSDLAVSAI
GVISQIIFFLMIISMMVSTGTGILIGQYNGSGRTQQSTDVAVASVVLGGI
LGLGLSLFAFFAANPIVIMYGLESDVATFAYDYLIITGSFTLTVTLGIVF
STILRSNGYSRTPMIVNLLTGGLNIFGNYCALYQPFGLPVYGVQGVAVAT
AFSQVINTIILWIMIHRKHIALPMMSFKKIPQTTYKKIMHIGVMNAGEML
SYNLSQMVIVYLVVRMGTASLTAFTYAQNIARVSFAFALAVGQASQIQTS
YYVGKKWIEQILTRVQIYFLISFAVSVALTCIVFFFRYELLDIFTQDPEV
ITLTAGLIAGSILVEAGRVFNLVFISALKGTGDIKFPVQLGILSMWGVAV
SLTYLLGVQFGFGVLGAWLALAADEWVRGVIMARRWRSKVWTKFNLI
>VFA0538 type I restriction-modification system specificity subunit
MLDMEAVKNFSIDKSDWKKVKFGDVVFEPKESVKDPVSEGIEHVVGLEHI
ESGDMYLRRSASIEGSTTFTKKFVKGDVLFGRRRAYLKKAAKAKFSGICS
GDITVMRARDELLLPDLVPFIVNNEKFFDYAITHSAGGLSPRVKFKDLAN
FEFFIPSKTDQKKLLSLLEGLDESLQNELILKQKLVSNLEAQIEHQIHGE
HLDGKTINQVIKSLSSKKKIIKLKGLGEIIKGKGIAKSEVVESGIPCVRY
GELYTKHHRMIRKFHSYISLKSSEKSVKLRVNDVLFAGSGETISEIGKSA
AFTESVDAYAGSDILIFRPKDMDGSYLGYLMNSLLVRHQLNKLGTGATVM
HVYGSDIQKIVVPYRDKDEQVQIANCLEEIASNIRLLDRKIHKTKELLAV
LLSKVF
>VFA0509 multidrug resistance ABC transporter ATP-binding and permease protein
MFKFFERLTTAFPEQEPNQPPKGLYAFCRHYTKGFEVPLIGMSLLSAVIA
MIEVSLFGFMGQLVDWLSTHDRETFLAQEGQTLLLLGFLIVVIVPILLFI
HSLLTHQTLLGNYPMAIRWQAHRYLLKQSVSFYSDDFAGRIATKVMQTAL
AVRETVMKLLDVLVYVSVYFTSMVVMVGQADWRLMLPMLVWFAAYVAIQF
HFVPKLKAISEQQADARSTMTGRVVDSYTNINTVKLFSHSKRETQYAEEG
MEEFLGTVHKQMRLATGINISVEIINYLLVFSIAAVSITLWLDNVLSVGA
IAIAISLALRVNGMSHWIMWEISSLFENLGTVTDGINTLSKPIEITDKEN
ASELNVSKGTIKFDSVNFNYGENKSVINDLNLEIKPGEKIGLVGRSGAGK
STLVNLLLRFHDVESGSISIDGQDIRDVTQDSLRSQIGMVSQDTSLLHRS
IRDNIKYGRPDATDEDLFAATKQAQAHEFIETLTDSFGSKGYDAQVGERG
VKLSGGQRQRIAISRVLLKDAPLLILDEATSALDSEVEAAIQDSLDELME
GKTVIAIAHRLSTIAAMDRLLVMDKGQVVEQGTHKELVALGGIYAQLWNH
QTGGFISE
>VFA1149 acriflavin resistance plasma membrane protein
MLSRFFIQRPKFALVISIILTLAGAIALAVLPVAEYPKISPPSVSVSAYY
TGASAEVVEQAIADPIETSVNGVENMIYMSSKSANDGSYSLNVTFDVGTD
PDMAQVNVQNRVAQIESKLPQEVRMVGVTVKKRSPDLLMVLNFYSPDGKY
DDQFLINYVNLNIKDQLARVTGISEVGVLGGGEYAMRVWLDPDKMTNLGL
TTSDVHAALAEQNVQVAAGKIGAAPYASAQDVQFNLVTKGRLESVEEFEN
VVLRANNDGSSVYLKDIARVELGKKFYDGNGQFRGKDASIVTLSLQSDAN
ALESGKAVMEMLEKLSATFPEGLAYETSYDTTLFVSESIKGVVKTLIEAI
LLVIAVTYLFLGSARATLIPVVAIPVSLIGTFAVMLMTGFTINTVTLFGL
ILAIGIVVDDAILVIENVDTIMKRDPSLSPRKATLIAMKEVTGPIITSTL
VLLAVFIPVAMLPGITGIMYRQFALTICIAVIISSINALTLSPALCSLVL
KRGGDNTARWFKAFNRGLDKVTDKYGEIAGFFVRKTMILMTFFVIALGAV
TFFAKTTSTAFVPQEDKGILLVNVQLPDSASLSRTEEVSAKVLEIIEQEQ
GVDGVTVANGYAFLTGAAASNGASLFVKLKPWGERNDMDGDNSSFAITNR
INGRAAMELPEAVIFAMGAPAVPGMGAASGFEFVLEDTLGRSRTDLANVM
NQVIQTANQQPEIQYTFSTFRANVPHYYVDIDREKAKQLGVSLGSIFQTL
QGNLGSMYVNDFTMFGKNFRVTMQADGQYRSSMDDLDKFHVRASSGQMVP
LSTLVTYDTVFEPDVAWRYNMYRSAVIQGQPAAGYSSGDAIAAMERVAAE
VLPHGYQYEWTGMAYQEVKAGNQAIYAFALALIFIYLFMVAQYESWSIPL
AIILVVPVATFGSFLALNLTGMPLNLYAQIGLVLLIALAAKNAILIVEFA
KNEREEKEVGLDDASVNGGRLRFRAVNMTSWSFILGILPLVFASGAGYIS
QNSLGVSLIGGLLCVLLVGTLLIPGFYAMVQRRREKLHGGSTKLIPLDDE
>VFA0907 acriflavin resistance plasma membrane protein
MLSKFFIHRPKFALVISLVMTLMGLIALKVLPIAEYPAISPTVIIVNTVY
PGANADVVKKTVAQPLESKINGVEDMIYMSSNIGNDGSYSLRVYFRIGAD
GDMAQVRVNNLVSQATSTLPPEVKQIGVTVRKKSSDILGVVTLSSPNKTY
DSIYLSNYADLNLVERLKRLEGMSDITLLGKKSYSMRIWLNPNKMSTLNL
TAKDVISAVKSQNIQVAAGKIGGMPAPDQQQNQYVLQTKGRLTSTDEFAN
IVIRANKDGSIIRLSDVARLELGAQGYEADGQLNNQPAAVMALYQLPTAN
ALDAMSKVKAAMKEYSKTFPDDLEYNIAYDSTEYVEASIDEVYETLIIAA
LLVAIVVYVFLQNLRATAIPIIAIPVSIIATFAVMSLMGMTINTISLFGL
ILAIGIVVDDAIIVVENVERIIHEKHMKPIPATIEAMKEVTGPVLATTLI
LLAVFVPVALLPGISGKMFNQFAVTICVSVLISAINALTLSPALCGLILT
DKHSEPIAPLRAFNRGFDAVTKKYQFLVGFMSQRLLVSSVIYIALIGVLG
YTFMTIPTAFVPNEDKGAFMVEMRLPDSASLQRTIPILQDYTRDLLEMDG
VEDVVSVSGFSLINMSAIPNAGMLIIKLNNWDDRKDPALHQKALMNKVRQ
MLNTIPNANALVFATPAIRGMGSVDGFNFVLEDNLGRSPQELAQTTQNFV
AKINQLPEVARAFSIFRANVPQRFIDVDRDKAISMGIPLNDIFQTLQSQL
GGAYISDFNIYGRSFQVKVQAEQEYRDSTDDINNLYVRNNTGKMVSLGTL
VKIKPIFGPDSLMNYNLFGSATINGVPASGYSSGDVVKAIEKLAENELPK
GYSFEWSGMTYQELEAGNAAPVAFALSLLFTYLFLVAQYESWSIPTAVMM
AVPIAILGAMATLFALGQPFDLYVQIGIVILIGMSAKVAILIVEFAKVLR
EEKGYSIIEAAKEAARLRFRAVQMTAFAFIWGVFPLVIASGAGAESRHSL
GFAVFGGMILSTLIGTIFTPVFFVTMQSLRERFNPKK
>VF1165 ABC transporter ATP-binding protein
MNNHHKQRGGTSLIKDLVTLRDISKHYKNGTEEVRALDGVSLSIKKGEFL
SILGPSGSGKSTLMNMLGCLDTPTVGKYYLDSKDVSVLSSHQLASIRNQS
IGFVFQSFNLLEYASALDNVALPLVYGGVKIAERKQKAAALLERVGLGDR
MNHKPNQLSGGQKQRVAIARALVNDPQIILADEPTGALDSKSGADIEALF
NELHQEGRTLIIVTHDNALAQRTKRIINIKDGKIITDEYLA
>VFA0111 daunorubicin resistance ATP-binding protein DrrA
MTELAIQAKEVVKKFGDFTAIDGINLSVPKGSIYGFLGPNGCGKSTTIRT
LTGLLSPTSGTVDVLGLCIPKESEALRLKIGYMTQKFSLYDDLSVEENLE
FIGQIFGMEKQLLNARVSEQLATYGLDQLRKQRVSGMSGGQKQRLSLAAA
TMHNPELLFLDEPTSAVDPENRREFWEQLFDLSDKGTTILVTTHYMDEAE
RCHRLAIMESGIIRADGEPEELMANMGVNIVEVKANNLRALKAKLIACDE
VRSAAQLGIRLRVLIHQHIDDPILWLRTNFSELKDAEMNIARPSLEDVFV
TVTGKGRQ
>VF1184 acriflavin resistance plasma membrane protein
MSQEKGIAAYFIQNKVISWMLTLIFMIGGTSAFFGLGRLEDPAFTIKDAM
VVTNYPGATPEQVEEEVTYPLEKAIQQLTYVDEVNSLSSRGLSQITVTMK
NNYGPDDLPQIWDELRRKVNDLKRQLPPGVGEPSVIDDFGDVYGVLLAVT
GKGYSYKEILDYVDYLRRELELVDGVSKVSVSGVQQEQVFIEASLKRMTS
LGISPQTLYSLLSNQNTVSSAGAVKIGTEYIQIHPTGEFEDVAQLGDLII
TDGGAQGLIYLKDIAEVKRGYVEVPSNIVNFNGNFALNLGVSFSAGVNVV
EIGKLVDQRMAELKEQQPIGIDISEIYSQPKEVDKSVSGFVVSLGQAVAI
VIIVLLFFMGVRSGLLIGLILLLTVAGTFVFMKYFAIDLQRISLGALVIA
LGMLVDNAIVVVEGILIGMQKGRTRLQAATDIVTQTKWPLLGATVIAVTA
FAPIGLSDDATGEYCGTLFTVLLISLMLSWFTAISLTPFFASLFFKERVQ
SEEESLEEKDPYNGMIFVVYKRFLEFCMRYSVATMVILVVALGGSLYGFT
KVKQSFFPSSTTPIFMVDVWMPEGTDIRSTNATLKELEEWILEQQHIEHV
TTTAGKGLQRFMLTYAPEKSYAAYGEIMTRVDNYEALQPLMAKFRQHIED
QYPQIQYKLKQIELGPGGGAKVEARIVGADPTVLRGLAAQVIDIMHNDPG
ATNVRHDWRERTKVLEPQFNESQARRYGISKTDVNELLEMAFSGKAIGVY
RDGTTLMPIVTRLPENERVDISTIEGMKIWSPALSQYIPLQQVVLGYDVI
WEDPQIVRKNRKRMLTVMADPDILGEETAATLQKRLQTQIEAIDFPTGYS
LEWGGEYESSRDAQASLFQTMPLGYLFMFLVTVFLFNSVKESVIVWLTVP
LAIIGVTSGLLLLNTPFGFMALLGFLSLSGMLLKNGIVLLDQIEIEIKSG
KEPYHAVVDAALSRVRPVCMAAITTILGMIPLLPDIFFKPMAVTIMFGLG
FATVLTLIVVPVLYRMFHRIKVVEY
>VFA0537 type I restriction-modification system methylation subunit
MMTQQELEKYLWGAATTLRGTIDAGDYKQYIFPLMFFKRICDVYDEEFEN
ALAESDGDLEYAAFAENHHFQVPKGAHWNDVRETTTNIGLALQNAMRAIE
KANPDTLEGIFGDASWTNKERLSDAMLTNLIEHYSEQTLNLKNVPDDKLG
NAYEYLIKEFADDSGHTAAEFYTNRTVVKLMTMIMAPQPGESVYDPTCGS
GGLLLNCALHLKDEGKEYRTLKLYGQEINLLTSAIARMNMFMHGIEEFDI
VRGNTLSNPGLLENDELKKFNVILANPPYSIKSWDRKAFESDPYGRNVWG
TPPQGCADYAFQQHIQKSLDLGNGRSISLWPHGILFRDAETAMRRKMIEQ
DQVECVIGLGPNLFYNSPMEACLLITKTNKIESKKDKILFINAVKEVRQD
KNIGYLDQVHIDKIFNAYNKFENEDSFAVLVDKQEVLDKKANMAINLYIR
PDSLVSSEEACFATAYQEWQQSSGDLKQSMEKLFKELV
>VF1415 Na(+) driven multidrug efflux pump
MHRYQKEIVRLIKLSTPVLIASVAQTGMGFVDTVMAGGVSATDMAAVAIA
ASVWLPSVLFGVGLLMALVPVVAQLNGSGKSKKVPFEIHQGVYLALLTSI
PIMLVLYNAGFIIAAMDVEPELYEKTQGYLHAVLWAAPAFLLFQTLRSFC
EGLSLTTPAMIIGFIGLAANVPLNWMFVYGELGAPALGGVGCGVATAIVY
WLMFLTMTLYTFIAPKLRRVNLYENWNKPQRKEIYRLFKLGLPVALSIFF
EVTLFAAVALLVSPLGSTVVAAHQVAINFSSLIFMIPMSIAVAVSIRVGH
KLGEKDLDGAKVASYCGLAFGLLMACCTAILTLIFREQIAYLYSDNQEVI
TLAVSLMLLAAIYQCTDAVQVVAAGALRGYKDMNAIFKCTFVSYWIVGLP
SGYVLGMTDWIREPMGVYGFWFGFIGGLTTSAILLTCRLLWLQRNPTRID
MEVDELQIMH